RBLU vs. FTXH
RBLU (T-Rex 2X Long RBLX Daily Target ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both exchange-traded funds - RBLU is a Leveraged Equities fund tracking the Roblox Corp. Class A (RBLX), while FTXH is a Health & Biotech Equities fund tracking the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past year, RBLU returned -96.05% vs 49.44% for FTXH. Their -0.06 correlation means they have often moved in opposite directions in the past. RBLU charges 1.05%/yr vs 0.60%/yr for FTXH.
Performance
RBLU vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RBLU achieves a -88.47% return, which is significantly lower than FTXH's 17.64% return.
RBLU
- 1D
- 6.33%
- 1M
- -63.24%
- 6M
- -82.19%
- YTD
- -88.47%
- 1Y
- -96.05%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -74.71%
FTXH
- 1D
- -0.77%
- 1M
- -1.43%
- 6M
- 12.69%
- YTD
- 17.64%
- 1Y
- 49.44%
- 3Y*
- 15.53%
- 5Y*
- 9.04%
- 10Y*
- —
- ALL TIME*
- 8.02%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $132.42M | $64.10M | $22.26M | |
| $3.87M | $2.37M | $2.31M |
RBLU vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
RBLU T-Rex 2X Long RBLX Daily Target ETF | -88.47% | 23.90% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 17.64% | 18.83% |
Correlation
The correlation between RBLU and FTXH is -0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.08 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2025 | -0.06 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RBLU vs. FTXH — Risk / Return Rank
RBLU
FTXH
RBLU vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T-Rex 2X Long RBLX Daily Target ETF (RBLU) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RBLU | FTXH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.63 | ||
| Sortino ratioReturn per unit of downside risk | -6.30 | ||
| Omega ratioGain probability vs. loss probability | 0.74 | 1.48 | -0.74 |
| Calmar ratioReturn relative to maximum drawdown | -0.99 | 6.65 | -7.64 |
| Martin ratioReturn relative to average drawdown | -1.34 | 19.78 | -21.12 |
Loading charts...
Drawdowns
RBLU vs. FTXH - Drawdown Comparison
The maximum RBLU drawdown since its inception was -96.97%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for RBLU and FTXH.
Loading charts...
Drawdown Indicators
| RBLU | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.97% | -32.11% | -64.86% |
Max Drawdown (1Y)Largest decline over 1 year | -96.92% | -7.47% | -89.45% |
Max Drawdown (3Y)Largest decline over 3 years | — | -19.51% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.51% | — |
Current DrawdownCurrent decline from peak | -96.78% | -2.77% | -94.01% |
Average DrawdownAverage peak-to-trough decline | -48.52% | -5.76% | -42.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 71.70% | 2.51% | +69.19% |
Volatility
RBLU vs. FTXH - Volatility Comparison
T-Rex 2X Long RBLX Daily Target ETF (RBLU) has a higher volatility of 82.34% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 4.91%. This indicates that RBLU's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RBLU | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 82.34% | 4.91% | +77.43% |
Volatility (6M)Calculated over the trailing 6-month period | 126.24% | 12.81% | +113.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 135.50% | 17.04% | +118.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 127.71% | 16.53% | +111.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 127.71% | 18.43% | +109.28% |
RBLU vs. FTXH - Expense Ratio Comparison
RBLU has a 1.05% expense ratio, which is higher than FTXH's 0.60% expense ratio.
Dividends
RBLU vs. FTXH - Dividend Comparison
RBLU's dividend yield for the trailing twelve months is around 11.23%, more than FTXH's 1.10% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.10% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
RBLU T-Rex 2X Long RBLX Daily Target ETF | 11.23% | 1.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RBLU and FTXH have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RBLU has higher volatility (82.34%) compared to FTXH (4.91%). In terms of maximum drawdown, RBLU dropped -96.97% vs FTXH's -32.11%.
On 1-year performance, FTXH leads with 49.44% vs -96.05% for RBLU. On fees, FTXH is cheaper at 0.60% per year. On volatility, FTXH has been the lower-risk option at 4.91%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, FTXH has performed better with a 49.44% return vs -96.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FTXH is cheaper with a 0.60% expense ratio, compared with 1.05% for RBLU.
RBLU has the higher dividend yield at 11.23%, compared with 1.10% for FTXH.
RBLU is categorized as Leveraged Equities, while FTXH is Health & Biotech Equities. RBLU tracks Roblox Corp. Class A (RBLX), while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: T-Rex and First Trust. Their fees differ too: 1.05% for RBLU and 0.60% for FTXH.
FTXH currently has the higher Sharpe Ratio (2.92 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RBLU and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer